Ma, T. M. et al. Local failure events in prostate cancer treated with radiotherapy: a pooled analysis of 18 randomized trials from the meta-analysis of randomized trials in cancer of the prostate consortium (LEVIATHAN). Eur. Urol. 82, 487–498 (2022).
Valle, L. F. et al. A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER). Eur. Urol. 80, 280–292 (2021).
Matei, D. V. et al. Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approaches. Urol. Int. 94, 373–382 (2015).
Kanthabalan, A. et al. Intraprostatic cancer recurrence following radical radiotherapy on transperineal template mapping biopsy: implications for focal ablative salvage therapy. J. Urol. 204, 950–955 (2020).
Article CAS PubMed Google Scholar
Davalos, R. V., Mir, L. M. & Rubinsky, B. Tissue ablation with irreversible electroporation. Ann. Biomed. Eng. 33, 223–231 (2005).
Article CAS PubMed Google Scholar
Blazevski, A. et al. Salvage irreversible electroporation for radio-recurrent prostate cancer – the prospective FIRE trial. BJU Int. https://doi.org/10.1111/bju.15947 (2022).
Article PubMed PubMed Central Google Scholar
Geboers, B. et al. Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer. BJU Int. https://doi.org/10.1111/bju.15948 (2023).
Marra, G. et al. The SAFE Pilot Trial — SAlvage Focal Irreversible Electroporation — for recurrent localized prostate cancer: rationale and study protocol. Front. Surg. https://doi.org/10.3389/fsurg.2022.900528 (2022).
Article PubMed PubMed Central Google Scholar
Jansen, B. H. E. et al. Detection of recurrent prostate cancer using prostate-specific membrane antigen positron emission tomography in patients not meeting the Phoenix criteria for biochemical recurrence after curative radiotherapy. Eur. Urol. Oncol. 4, 821–825 (2021).
留言 (0)